Insider · CIK 0001238120

Donenberg Phillip B.

Reports to the SEC for 7 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001238120

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	FTHFaeth Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2026-06-09	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,200
2026-06-01	TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award	Director	AAward	+42.7K sh	—	—	42,671
2026-06-01	TSHATaysha Gene Therapies, Inc.A Award	Director	AAward	+21.3K sh	—	—	241,289
2026-04-10	FTHFaeth Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.1K sh	—	—	23,100
2026-02-13	FTHFaeth Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+1,900 sh	—	—	1,900
2025-06-09	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,200
2025-06-02	TSHATaysha Gene Therapies, Inc.A Award	Director	AAward	+56.6K sh	—	—	219,954
2025-06-02	TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award	Director	AAward	+113K sh	—	—	113,246
2024-06-20	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.8K sh	—	—	11,760
2024-05-29	TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award	Director	AAward	+98.4K sh	—	—	98,440
2024-05-29	TSHATaysha Gene Therapies, Inc.A Award	Director	AAward	+49.2K sh	—	—	163,331
2023-08-16	TSHATaysha Gene Therapies, Inc.P Purchase	Director	PPurchase	+111K sh	$0.90	+$100K	114,111
2023-06-22	TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award	Director	AAward	+36.2K sh	—	—	36,200
2023-06-06	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,643
2022-06-17	TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2022-06-08	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,478
2022-06-08	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,478
2022-02-02	TSHATaysha Gene Therapies, Inc.P Purchase	Director	PPurchase	+3,000 sh	$7.78	+$23.3K	3,000
2021-06-17	TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2021-06-10	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.4K sh	—	—	17,438
2021-02-17	TECXTectonic Therapeutic, Inc.P Purchase	Director	PPurchase	+2,000 sh	$11.71	+$23.4K	2,000
2020-09-23	TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31K sh	—	—	31,000
2020-06-04	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2019-06-11	TECXTectonic Therapeutic, Inc. · Stock Option (Right to BuyA Award	Director	AAward	+9,675 sh	—	—	9,675
2018-07-16	Assertio Therapeutics, IncRestricted Stock UnitA Award	SVP and CFO	AAward	+87.2K sh	—	—	87,163
2018-06-20	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.7K sh	—	—	18,743
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−15K sh	—	—	0
2018-05-15	AveXis, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	+3,800 sh	—	—	3,800
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−20K sh	—	—	0
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−5,594 sh	—	—	0
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−4,406 sh	—	—	0
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−10K sh	—	—	0
2018-03-13	AveXis, Inc.A Award	Chief Financial Officer	AAward	+3,800 sh	—	—	3,800
2018-03-13	AveXis, Inc.Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+15K sh	—	—	15,000
2017-10-19	AveXis, Inc.Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+10K sh	—	—	10,000
2014-07-24	CRVOCervoMed Inc. · Stock Option (right to buy)A Award	Director	AAward	+271K sh	—	—	271,475
2012-01-25	ANIPANI PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	Sr VP of Finance, CFO, Secy	AAward	+285K sh	—	—	285,000
2011-08-08	ANIPANI PHARMACEUTICALS INCP Purchase	Sr VP of Finance, CFO, Secy	PPurchase	+1,000 sh	$2.23	+$2,230	44,322
2011-08-05	ANIPANI PHARMACEUTICALS INCP Purchase	Sr VP of Finance, CFO, Secy	PPurchase	+1,000 sh	$2.19	+$2,190	43,322
2011-01-21	ANIPANI PHARMACEUTICALS INCP Purchase	Sr VP of Finance, CFO, Secy	PPurchase	+1,000 sh	$1.88	+$1,880	42,322
2011-01-19	ANIPANI PHARMACEUTICALS INCP Purchase	Sr VP of Finance, CFO, Secy	PPurchase	+1,000 sh	$1.88	+$1,879.9	41,322
2011-01-03	ANIPANI PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	Sr VP of Finance, CFO, Secy	AAward	+270K sh	—	—	270,000
2010-02-02	ANIPANI PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	Sr VP of Finance, CFO, Secy	AAward	+100K sh	—	—	100,000
2009-02-02	ANIPANI PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	Sr VP of Finance, CFO, Secy	AAward	+125K sh	—	—	125,000
2008-12-31	ANIPANI PHARMACEUTICALS INCP Purchase	Sr VP of Finance, CFO, Secy	PPurchase	+3,000 sh	$1.00	+$3,000	40,322
2007-02-19	ANIPANI PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	Sr VP of Finance, CFO, Secy	AAward	+20K sh	—	—	20,000
2007-01-12	ANIPANI PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	Sr VP of Finance, CFO, Secy	AAward	+50K sh	—	—	50,000
2006-03-16	ANIPANI PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	Sr VP of Finance, CFO, Secy	AAward	+62.5K sh	—	—	62,500
2005-07-19	ANIPANI PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	Sr VP of Finance, CFO, Secy	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Jun 124
Donenberg Phillip B.0001238120-26-000011
SEC(opens sec.gov)
Jun 104
Donenberg Phillip B.0001238120-26-000010
SEC(opens sec.gov)
Jun 24
Donenberg Phillip B.0001238120-26-000008
SEC(opens sec.gov)
Apr 144
Donenberg Phillip B.0001238120-26-000006
SEC(opens sec.gov)
Feb 174
Donenberg Phillip B.0001238120-26-000004
SEC(opens sec.gov)
Jun 114
Donenberg Phillip B.0001415889-25-016676
SEC(opens sec.gov)
Jun 44
Donenberg Phillip B.0001415889-25-015573
SEC(opens sec.gov)
Jun 244
Donenberg Phillip B.0001415889-24-017998
SEC(opens sec.gov)
May 314
Donenberg Phillip B.0001415889-24-015039
SEC(opens sec.gov)
Aug 164
Donenberg Phillip B.0001209191-23-046148
SEC(opens sec.gov)
Jun 264
Donenberg Phillip B.0001209191-23-039731
SEC(opens sec.gov)
Jun 84
Donenberg Phillip B.0001127602-23-018290
SEC(opens sec.gov)
Jun 224
Donenberg Phillip B.0001209191-22-038691
SEC(opens sec.gov)
Jun 104
Donenberg Phillip B.0001127602-22-017246
SEC(opens sec.gov)
Feb 34
Donenberg Phillip B.0001209191-22-006641
SEC(opens sec.gov)
Jun 214
Donenberg Phillip B.0001209191-21-042112
SEC(opens sec.gov)

Companies

Address

C/O SENSEI BIOTHERAPEUTICS, INC. 1405 RESEARCH BLVD, SUITE 125

ROCKVILLE, MD, 20850